Page last updated: 2024-08-21

adamantane and natriuretic peptide, brain

adamantane has been researched along with natriuretic peptide, brain in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (14.29)	29.6817
2010's	4 (57.14)	24.3611
2020's	2 (28.57)	2.80

Authors

Authors	Studies
Brandt, I; De Meester, I; Ketelslegers, JM; Lambeir, AM; Scharpé, S; Vanderheyden, M	1
Ando, K; Irako, T; Nishimura, R; Sakamoto, M; Tsujino, D; Utsunomiya, K	1
Bhatt, DL; Braunwald, E; Cavender, MA; Davidson, J; Frederich, R; Hirshberg, B; Im, K; Jarolim, P; Lewis, BS; McGuire, DK; Morrow, DA; Mosenzon, O; Pollack, PS; Raz, I; Scirica, BM; Steg, PG; Udell, JA; Umez-Eronini, AA	1
Nishikido, T; Node, K; Ohira, H; Oyama, J	1
Baines, CP; Burnett, JC; Chakir, K; Cruz Rivera, N; Domeier, TL; Dozier, DG; Emter, CA; Ferguson, BS; Gutiérrez-Aguilar, M; Heublein, DM; Hiemstra, JA; Ivey, JR; Krenz, M; Lee, DI; Marshall, KD; McDonald, KS; Minervini, G; Scherf, C; Zgoda, PJ	1
Feng, X; Gao, G; Gu, Q; Li, Q; Yuan, L; Zhang, Y	1
Altaha, M; Bello, O; Connelly, KA; Garg, V; Ong, JP; Sandhu, P; Singal, SR; Verma, S; Yan, AT	1

Trials

5 trial(s) available for adamantane and natriuretic peptide, brain

Article	Year
Comparison of vildagliptin twice daily vs. sitagliptin once daily using continuous glucose monitoring (CGM): crossover pilot study (J-VICTORIA study). Cardiovascular diabetology, 2012, Aug-06, Volume: 11 Topics: Adamantane; Adult; Aged; Biomarkers; Blood Glucose; C-Peptide; Cross-Over Studies; Deoxyglucose; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Administration Schedule; Female; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Japan; Male; Middle Aged; Monitoring, Ambulatory; Natriuretic Peptide, Brain; Nitriles; Pilot Projects; Plasminogen Activator Inhibitor 1; Postprandial Period; Predictive Value of Tests; Pyrazines; Pyrrolidines; Serum Albumin; Sitagliptin Phosphate; Time Factors; Treatment Outcome; Triazoles; Vildagliptin	2012
Heart failure, saxagliptin, and diabetes mellitus: observations from the SAVOR-TIMI 53 randomized trial. Circulation, 2014, Oct-28, Volume: 130, Issue:18 Topics: Adamantane; Aged; C-Reactive Protein; Diabetes Mellitus, Type 2; Dipeptides; Dipeptidyl-Peptidase IV Inhibitors; Female; Follow-Up Studies; Heart Failure; Hospitalization; Humans; Male; Middle Aged; Multivariate Analysis; Natriuretic Peptide, Brain; Peptide Fragments; Risk Assessment; Troponin T	2014
The effects and safety of vildagliptin on cardiac function after acute myocardial infarction. International journal of cardiology, 2015, Jun-01, Volume: 188 Topics: Adamantane; Aged; Diabetes Mellitus, Type 2; Echocardiography, Doppler; Electrocardiography; Female; Follow-Up Studies; Glomerular Filtration Rate; Glycated Hemoglobin; Heart Function Tests; Humans; Incretins; Male; Middle Aged; Myocardial Infarction; Natriuretic Peptide, Brain; Nitriles; Pyrrolidines; Reference Values; Risk Assessment; Stroke Volume; Treatment Outcome; Vildagliptin	2015
The plasma levels of atrial natriuretic peptide and brain natriuretic peptide in type 2 diabetes treated with sodium-glucose cotransporter-2 inhibitor. Annales d'endocrinologie, 2020, Volume: 81, Issue:5 Topics: Adamantane; Adolescent; Adult; Aged; Aged, 80 and over; Atrial Natriuretic Factor; Benzhydryl Compounds; Blood Glucose; Diabetes Mellitus, Type 2; Dipeptides; Female; Glucosides; Glycated Hemoglobin; Humans; Insulin; Male; Middle Aged; Natriuretic Peptide, Brain; Sodium-Glucose Transporter 2 Inhibitors; Treatment Outcome; Young Adult	2020
The effects of saxagliptin on cardiac structure and function using cardiac MRI (SCARF). Acta diabetologica, 2021, Volume: 58, Issue:5 Topics: Adamantane; Aged; Biomarkers; C-Reactive Protein; Cohort Studies; Diabetes Mellitus, Type 2; Dipeptides; Female; Follow-Up Studies; Heart; Heart Ventricles; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Myocardium; Natriuretic Peptide, Brain; Peptide Fragments; Prospective Studies; Stroke Volume; Ventricular Function, Left	2021

Other Studies

2 other study(ies) available for adamantane and natriuretic peptide, brain

Article	Year
Dipeptidyl-peptidase IV converts intact B-type natriuretic peptide into its des-SerPro form. Clinical chemistry, 2006, Volume: 52, Issue:1 Topics: Adamantane; Atrial Natriuretic Factor; Dipeptides; Dipeptidyl Peptidase 4; Humans; Hydrolysis; In Vitro Techniques; Kinetics; Natriuretic Peptide, Brain; Neprilysin; Nitriles; Peptide Fragments; Protease Inhibitors; Pyrrolidines; Vildagliptin	2006
Saxagliptin and Tadalafil Differentially Alter Cyclic Guanosine Monophosphate (cGMP) Signaling and Left Ventricular Function in Aortic-Banded Mini-Swine. Journal of the American Heart Association, 2016, Apr-20, Volume: 5, Issue:4 Topics: Adamantane; Animals; Atrial Natriuretic Factor; Cyclic GMP; Dipeptides; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Echocardiography; Hypertrophy, Left Ventricular; Male; Natriuretic Peptide, Brain; Neuropeptide Y; Phosphodiesterase 5 Inhibitors; Signal Transduction; Swine; Swine, Miniature; Tadalafil; Ventricular Function, Left	2016

Article

Year

Dipeptidyl-peptidase IV converts intact B-type natriuretic peptide into its des-SerPro form.

Clinical chemistry, 2006, Volume: 52, Issue:1

Topics: Adamantane; Atrial Natriuretic Factor; Dipeptides; Dipeptidyl Peptidase 4; Humans; Hydrolysis; In Vitro Techniques; Kinetics; Natriuretic Peptide, Brain; Neprilysin; Nitriles; Peptide Fragments; Protease Inhibitors; Pyrrolidines; Vildagliptin

2006

Saxagliptin and Tadalafil Differentially Alter Cyclic Guanosine Monophosphate (cGMP) Signaling and Left Ventricular Function in Aortic-Banded Mini-Swine.

Journal of the American Heart Association, 2016, Apr-20, Volume: 5, Issue:4

Topics: Adamantane; Animals; Atrial Natriuretic Factor; Cyclic GMP; Dipeptides; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Echocardiography; Hypertrophy, Left Ventricular; Male; Natriuretic Peptide, Brain; Neuropeptide Y; Phosphodiesterase 5 Inhibitors; Signal Transduction; Swine; Swine, Miniature; Tadalafil; Ventricular Function, Left

2016